Search Clinical Trials

589,087 trials

NCT07644663
Not Yet RecruitingPhase 4
The Effects of Different Anesthetics on the Brain's Neural NetworksFudan University
NCT07643896
Recruiting
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk AssessmentBillionToOne Inc.
NCT07645573
RecruitingEarly Phase 1
18F-FTHA IMAGING OF THE INTESTINAL AND CENTRAL LYMPHATIC SYSTEMUniversity of Pennsylvania
NCT07644572
Enrolling By InvitationNot Applicable
Individualized Nutrition Intervention in Children With Cerebral PalsyGazi University
NCT07644910
Not Yet RecruitingNot Applicable
Nudging Preventive Screening Via Message Framing and BundlingUniversity of Chile
NCT07644598
Not Yet RecruitingPhase 2
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate CancerGeorgetown University
NCT07644364
Not Yet RecruitingPhase 1
HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With HypertensionNovartis Pharmaceuticals
NCT07645651
Not Yet RecruitingPhase 1
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic CancerCarrick Therapeutics Limited
NCT07644507
Not Yet Recruiting
Role of Intraoperative Computed Tomography in Assessment of Spine Instability in Lumbar Degenerative Disease4th Military Clinical Hospital with Polyclinic, Poland
NCT07645690
RecruitingEarly Phase 1
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell CarcinomaChinese PLA General Hospital
NCT07643818
Not Yet RecruitingPhase 2
Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron DeficiencyGovernment of Jersey
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07644767
Not Yet RecruitingPhase 2
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty Ltd
NCT07646496
CompletedNot Applicable
Comparison of Chest Compressions Performed With the Lower Limb and the Classical Method (Lower_limb_CPR).Marcin Muża
NCT07644780
CompletedNot Applicable
Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients SupplementsNutrition International
NCT07644819
Not Yet RecruitingNot Applicable
Preoperative Outreach to Improve Surgical AttendanceUniversity of California, San Francisco
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07645131
Not Yet RecruitingNot Applicable
Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use DisordersVA Office of Research and Development
NCT07646431
CompletedNot Applicable
Comparative Effects Of Clamshell And Short Arc Quadriceps Exercises In Patellofemoral PainGreen International University
NCT07645183
CompletedNot Applicable
Advanced Technology for Myopia Control in Children and Young AdultsUniversity of Faisalabad